Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working GroupAntonio Palumbo, Philippe Moreau, Hervé Avet‐Loiseau et al.|Journal of Clinical Oncology|2015Cited by 2.2k
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and AmyloidosisMorie A. Gertz, G Grateau, Ray Comenzo et al.|American Journal of Hematology|2005Cited by 1.4k
Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple MyelomaPhilippe Moreau, Paul G. Richardson|New England Journal of Medicine|2016Cited by 1.1k
Heterogeneity of genomic evolution and mutational profiles in multiple myelomaNiccolò Bolli, Nikhil C. Munshi, Hervé Avet‐Loiseau et al.|Nature Communications|2014Cited by 906
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group studyShaji Kumar, John Crowley, J. Haessler et al.|Leukemia|2011Cited by 721